A new melanoma drug that tricks the body into destroying cancer cells is keeping patients alive for years longer than expected, with some researchers calling the breakthrough in immunotherapy a “penicillin moment” in cancer treatments.
Kathy Gardiner and her fiancé, Anthony Pukallas, are due to get married in a fortnight.
The wedding did not seem likely just over a year ago when Kathy was diagnosed with terminal cancer.
CT scans showed five major tumours on her lungs.
“You go through a lot of emotions when you’re told that you have a terminal diagnosis,” Ms Gardiner told 7.30.
“You first progress with disbelief and then you go through trying to work out why this has happened to you, and eventually it’s the anger, and at that point you have to reach a level of acceptance.’
But now Ms Gardiner has been given a new chance at life.
When she was diagnosed, she was given an new immunotherapy drug called Pembrolizumab as part of the drug company’s compassionate access scheme.
After less than a year on Pembrolizumab, there is only one tumour visible on Ms Gardiner’s lungs.
Each new scan shows that the tumours have shrunk.
“The opportunity to have life extension is one of the best gifts that could be granted, Ms Gardiner said.
Pembrolizumab is one of a new class of melanoma drugs which is keeping some patients alive for years longer than previously expected.
The category of immunotherapy called anti-PD1 tricks the body’s immune system into destroying cancer cells.
And there is hope the drugs could be effective against other cancers.
For the first time, the national drugs regulator, the Therapeutic Goods Administration, approved an anti-PD1 drug for use against melanoma.
Pembrolizumab is hugely expensive – costing patients between $10,000 and $15,000 a month – but oncologists expect that it will be fast-tracked for subsidy under the Pharmaceutical Benefits Scheme (PBS).
The drug, also known by the trade name Keytruda, was also the subject of a study published on Monday in the New England Journal of Medicine.
The study said it was far more effective than existing treatments for advanced melanoma.
The Latest on: Melanoma
via Google News
The Latest on: Melanoma
- Researchers develop a wearable patch for melanomaon June 27, 2020 at 5:59 am
Purdue University researchers have designed an innovative skin patch that could deliver timed-release melanoma treatment painlessly and then dissolve.
- What Does Real-World Data Show for Adjuvant Immunotherapy in Melanoma?on June 26, 2020 at 12:16 pm
Having lower socioeconomic status, comorbidities, or being covered by Medicare was associated with less receipt of immunotherapy for stage III melanoma.
- Synoicum adareanum can provide a better understanding for the development of melanoma-specific drugon June 25, 2020 at 11:02 pm
Could the cure for melanoma - the most dangerous type of skin cancer - be a compound derived from a marine invertebrate that lives at the bottom of the ocean?
- New Study Demonstrates the Ability of myPath® Melanoma to Accurately Classify Lesions Ruled Indeterminate by Standard Pathological Assessmenton June 25, 2020 at 4:41 am
Myriad Genetics, Inc. (MYGN), a leader in molecular diagnostics and precision medicine, announced today that a new study published in Future Medicine demonstrates the ability of myPath® Melanoma to ...
- Single-cell sequencing of genomic DNA resolves sub-clonal heterogeneity in a melanoma cell lineon June 25, 2020 at 2:13 am
Through shallow single-cell sequencing of genomic DNA followed by clustering analysis, Velazquez-Villarreal et al. reveal sub-clones of the melanoma cell line COLO829 and further identify and validate ...
- Can Genetics Determine Risk for Melanoma Progression?on June 24, 2020 at 7:33 pm
New research finds that people with advanced melanoma skin cancer who’ve inherited an E (APOE) gene may have longer survival times and a better response to immunotherapy.
- Vulvar Melanoma Is Increasing in Older Womenon June 24, 2020 at 11:36 am
The national incidence of vulvar melanoma is on the rise in women older than 60 years, a study of epidemiologic trends shows.
- Innovative smartphone-camera adaptation images melanoma and non-melanomaon June 23, 2020 at 1:34 pm
Point-of-care, multispectral, smartphone-based dermascopes for dermal lesion screening and erythema monitoring," shows that standard smartphone technology can be adapted to image skin lesions, ...
- Polynoma Receives FDA Fast Track Designation for its Melanoma Cancer Vaccine Seviprotimut-Lon June 23, 2020 at 5:30 am
Polynoma LLC, a U.S. immuno-oncology focused biopharmaceutical company and wholly-owned subsidiary of Hong Kong-listed CK Life Sciences Int'l., (Holdings) Inc., announces that the U.S. Food and Drug ...
- Real-World Data Back Immunotherapy in Stage III Melanomaon June 22, 2020 at 3:17 pm
Treatment with adjuvant immunotherapy conferred a survival advantage for patients with resectable melanoma at the highest risk of relapse, real-world evidence from the National Cancer Database (NCDB) ...
via Bing News